Dapagliflozin a new approach in the treating patients with heart failure: DAPA – HF Trial MD Editorial Team14 Feb 2022 9:00 AM ISTCardiac health is very important as its one of the vital organs. Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an...
Omecamtiv mecarbil reduces CV death among patients with severe systolic heart failure: JAMA MD Editorial Team26 Oct 2021 9:00 AM ISTHeart failure with reduced ejection fraction is a progressive clinical syndrome, and many patients' condition worsen over time despite...
Physical activity decreases CVD mortality in patients on dialysis: Study Dr. Shravani Dali2 Oct 2021 9:00 AM ISTPatients on maintenance hemodialysis who engage in frequent physical activity are less likely to die from cardiovascular events compared with those...
Empagliflozin significantly reduces hospitalization risk in patients of HFpEF, shows trial Dr. Kamal Kant Kohli30 Aug 2021 6:00 AM ISTFrance: SGLT-2 inhibitor, Empagliflozin significantly reduced heart failure-related hospitalizations, regardless of patient diabetes status, reveal...
Early coronary angiography improves cardiovascular outcomes in patients with acute heart failure: Study Medha Baranwal16 Aug 2021 9:15 AM ISTCanada: Early coronary angiography during acute heart failure (HF) hospitalization is associated with lower HF readmissions, cardiovascular death,...
FDA grants expanded indication for sacubitril/valsartan in chronic heart failure Hina Zahid17 Feb 2021 11:00 AM ISTBasel - The US Food and Drug Administration (FDA) has approved the expanded indication for Entresto (sacubitril/valsartan) for reducing the risk of...
CVD mortality risk lower than average in flight crews compared to miners: BMJ Dr Satabdi Saha3 Dec 2020 1:00 PM ISTA systematic review evaluating intermittent exposure of workers to hypoxic conditions and the prevalence of certain types of cardiovascular diseases...
Outpatient use of Azithromycin increases risk of CVD and non CVD death: JAMA Medha Baranwal19 Jun 2020 3:15 PM ISTUSA: Outpatient azithromycin use increases the risk of cardiovascular (CV) death and noncardiovascular death, according to a recent study in...
Salt substitution may prevent half a million deaths from CVD in China Hina Zahid24 April 2020 12:00 PM ISTA nationwide intervention to replace regular household salt with potassium-enriched salt substitutes in China could prevent nearly half a million...
